Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Takeda Oncology, Genomic Health, and Novartis.

Community Practice Connections™: 2nd Annual European Congress on Immunotherapies in Cancer™

Release Date: January 30, 2018
Expiration Date: January 30, 2019
Media: Internet - based


Activity Overview

This activity focuses on immunotherapies in renal cell carcinoma, non–small cell lung cancer, and B-cell malignancies. It consists of a series of brief video interviews with leading experts and short summaries of clinical data related to issues discussed in the interviews. The content and videos are based on presentations given at the 2nd Annual European Congress on Immunotherapies in Cancer™, held September 22-23, 2017, in Barcelona, Spain. The program is designed for community oncologists, and addresses current standards of care and emerging concepts in cancer immunotherapy.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Takeda Oncology, Genomic Health, and Novartis.

CME/CE Activity Table of Contents

  • Module 1: Emerging Immunotherapeutic Strategies in Renal Cell Carcinoma
    Bernard Escudier, MD
  • Module 2: Is PD-L1 Expression a Useful Biomarker for Checkpoint Inhibitor Treatment in Patients With Lung Cancer?
    Roman Perez-Soler, MD
  • Module 3: Building a Better Chimeric Antigen Receptor T Cell
    Michel Sadelain, MD, PhD

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is intended for medical oncologists and other healthcare professionals (eg, physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants). Participants will primarily be those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Explain mechanistic approaches toward targeting the immune system to treat cancer
  • Evaluate the clinical applicability of data from clinical trials of immunotherapy strategies
  • Discuss methods to individualize the use of immunotherapy strategies, including the use of biomarkers
  • Describe how to proactively mitigate and manage adverse events associated with the use of treatment strategies in the care of patients with cancer
  • Identify unmet clinical needs in cancer treatment and highly anticipated clinical trials evaluating novel immunotherapeutic approaches

Faculty, Staff, and Planners' Disclosures


Bernard Escudier, MD
Chair, Genitourinary Oncology Committee
Gutave Roussy
Paris, France

Disclosure: Consultant/Advisory Boards: Pfizer, Novartis, Bristol-Myers Squibb, Roche, Exelixis, Ipsen

Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, New York, USA

Disclosure: Consultant/Advisory Boards: AstraZeneca, Clovis, Roche/Genentech, Boehringer Ingelheim, Lilly, Adgero

Michel Sadelain, MD, PhD
Director, Center for Cell Engineering & Gene Transfer and Gene Expression Laboratory
Stephen and Barbara Friedman Chair
Memorial Sloan Kettering Cancer Center
New York, New York, USA

Disclosure: Consultant/Advisory Boards: Juno Therapeutics

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Filter By